Safety First: Monitoring Hypoglycemia and Side Effects

While Mecasermin (recombinant human IGF-1) is a vital tool for growth, it is a powerful hormone that requires careful safety monitoring. Because IGF-1 is biologically similar to insulin, its most significant side effect is its ability to lower blood sugar. Managing Laron syndrome is as much about safety and metabolic balance as it is about height ^[1][2].

The Risk of Low Blood Sugar (Hypoglycemia)

Hypoglycemia is the most common serious side effect of treatment, occurring in approximately 18% of children ^[2]. Children with Laron syndrome are already prone to low blood sugar even before starting treatment; the medication increases this risk significantly ^[1].

Red Flags for Hypoglycemia
You must be able to recognize the difference between mild low blood sugar and a medical emergency. You should always have a written, individualized plan from your clinician.

• Mild to Moderate (Treat with fast-acting sugar): Your child may seem shaky, sweaty, pale, unusually hungry, irritable, or dizzy ^[1]. They might complain of a “racing heart” or a headache. Use a blood glucose meter if available, and provide an age- and weight-appropriate carbohydrate.
• Severe (Emergency—Call 911/Emergency Services): This is a critical situation. Red flags include:
  • Seizures or uncontrollable shaking.
  • Loss of consciousness or inability to wake up.
  • Confusion or extreme lethargy where they cannot follow simple commands.

Emergency Protocol

1. Never give a dose without food: Mecasermin must be given shortly before or after a meal or snack according to your specific local product label ^[1]. If your child is sick and not eating, skip the dose. Never give an extra dose for a missed dose.
2. Fast-acting Carbohydrates: Always carry a source of quick sugar (like glucose gel, juice, or glucose tablets) to treat mild symptoms immediately.
3. Glucagon for Severe Emergencies: Your doctor may prescribe an emergency glucagon kit. If your child is unconscious or seizing, NEVER give food, juice, or glucose by mouth as they can choke. Place them safely on their side, use prescribed glucagon, and call emergency services. Ensure all caregivers know where it is and how to use it.

Immediate Medical Red Flags

In addition to severe hypoglycemia, seek prompt medical assessment if you notice any of the following:

• Signs of Hypersensitivity: Hives, trouble breathing, or swelling of the face and lips.
• Limping or Hip/Knee Pain: Rapid growth can occasionally cause a Slipped Capital Femoral Epiphysis (SCFE).
• Worsening Scoliosis: Monitor for worsening back curvature or pain.

Monitoring for Sleep, Breathing, and Brain Pressure Issues

IGF-1 promotes the growth of many tissues, not just bones. One common side effect is lymphoid hypertrophy, where the tonsils and adenoids at the back of the throat grow larger ^[2]. This occurred in about 7.4% of children in a large study ^[2].

If the tonsils become too large, they can partially block the airway during sleep, leading to Obstructive Sleep Apnea (OSA) ^[3]. Watch for these signs:

• Loud, frequent snoring.
• Gasping or snorting sounds during sleep.
• “Pauses” in breathing while sleeping.
• Restless sleep or unusual sleeping positions (like sleeping with the neck hyper-extended).
• Excessive daytime sleepiness or mouth breathing during the day ^[3].

If you notice these signs, your doctor may refer you to an Ear, Nose, and Throat (ENT) specialist or order a sleep study. Note that routine ENT screening is usually symptom-directed.

Your doctor will also check for intracranial hypertension (increased pressure around the brain) ^[2]. However, if your child develops severe headaches, vomiting, or visual changes, these require prompt medical assessment rather than waiting for a periodic check.

Skin Health and Injection Sites

Because Mecasermin is injected into the fatty tissue under the skin, it can cause local changes over time.

• Lipohypertrophy: This is a thickening of the fatty tissue that feels like a firm or “rubbery” lump under the skin ^[2][4]. It happens in about 10.6% of patients ^[2].
• Injection Site Reactions: Redness, bruising, or mild pain at the site are also common ^[2].

Management: The most effective way to prevent these issues is to rotate injection sites religiously. Never use the exact same spot two days in a row. Use a “map” of the body (thighs, buttocks, abdomen, and upper arms) to ensure you are moving the injection site each time. If a lump (lipohypertrophy) develops, avoid that specific area until the tissue softens, as medication may not be absorbed correctly through thickened skin ^[4].

Long-term Growth Monitoring

Your care team will monitor your child’s weight and Body Mass Index (BMI) alongside their height. It is common for children on IGF-1 to gain weight or see an increase in BMI ^[5]. While some weight gain is a normal part of growth, excessive weight gain without a corresponding increase in height may require a doctor to re-evaluate the dose or the overall treatment plan ^[5][3].